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To cite this version: Porphyrins have been shown t o have clinical use in chemotherapy through their ability t o photosensitize tumor cells. We investigated the cytocidal activity of light-activated hematoporphyrin derivative HPN on peripheral blood cells from patients with acute myeloblastic leukemia (AhTL) in blast phase (60-90% blasts). In all specimens, erythrocytes were removed from mononu nuclear cells by Ficol-hypaque centrifugation. Incubation of cells with 20 M HPN and subsequent spectroscopic measurements revealed that HPN was preferentially taken up into blast cells more than 10-fold greater than controls. After incubation (6 m i d , cells were washed f r e e of exogenous HPN and then pulsed (10 hsec) with red light (625 nM) from a XeCl excimer pumped dye (Rhodamine 1016) laser. Cells were maintained a t 0 OC durin irradiation procedures and the total dosage of applied light $ was 125 j/cm . No immediate e f f e c t s such a s lysis or agglutination were observed. T.. .,jran . . . blue viabl!ity studies revealed that incubation of controls or leukemic cells with HPN before irradiation did not a l t e r viability. Laser irradiation experiments indicated t h a t viability was not altered in controls or HPN exposed controls. However, leukemic cells exposed t o HPN became destroyed (60% of the control) a f t e r exposure t o t h e laser beam. This study demonstrates t h a t human AML cells can be preferentially destroyed by laser irradiation a f t e r HPN exposure. These findings may have therapeutic potential in the destruction of leukemic cells in certain clinical situations.
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